,address1,city,zip,country,phone,fax,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,8 HaSatat Street,Hevel Modi'in,7178106,Israel,972 8 993 5000,972 8 993 5001,https://www.vblrx.com,Biotechnology,Healthcare,"Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.",7,"{'maxAge': 1, 'name': 'Prof. Dror  Harats M.D.', 'age': 65, 'title': 'CEO & Director', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 444333, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.2449,0.25,0.2303,0.25,0.2449,0.25,0.2303,0.25,0.0,0.817081,-0.39,192431,192431,1055709,538330,538330,0.23,0.24,1100,1000,18167876,0.101,0.32,37.771053,0.25498,0.194235,0.0,0.0,USD,-6096130,0.0,57676774,77640496,296716,517162,1690761600,1693440000,0.0038,0.13482,0.14050001,0.4,0.0039,0.273,0.85714287,1672444800,1703980800,1688083200,-15955000,-0.2,-0.6,-12.674,0.396,NCM,EQUITY,VBLT,VBLT,Vascular Biogenics Ltd.,Vascular Biogenics Ltd.,1412170200,America/New_York,EDT,-14400000,0.234,3.0,hold,24264000,0.313,-15413000,0,4.577,4.631,481000,0.006,-0.2912,-0.59521,554000,-10838875,-17592000,0.96466005,0.0,-33.88565,USD,
1,8 HaSatat Street,Hevel Modi'in,7178106,Israel,972 8 993 5000,972 8 993 5001,https://www.vblrx.com,Biotechnology,Healthcare,"Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.",7,"{'maxAge': 1, 'name': 'Mr. Samuel  Backenroth', 'age': 38, 'title': 'Chief Financial Officer', 'yearBorn': 1984, 'fiscalYear': 2022, 'totalPay': 410000, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.2449,0.25,0.2303,0.25,0.2449,0.25,0.2303,0.25,0.0,0.817081,-0.39,192431,192431,1055709,538330,538330,0.23,0.24,1100,1000,18167876,0.101,0.32,37.771053,0.25498,0.194235,0.0,0.0,USD,-6096130,0.0,57676774,77640496,296716,517162,1690761600,1693440000,0.0038,0.13482,0.14050001,0.4,0.0039,0.273,0.85714287,1672444800,1703980800,1688083200,-15955000,-0.2,-0.6,-12.674,0.396,NCM,EQUITY,VBLT,VBLT,Vascular Biogenics Ltd.,Vascular Biogenics Ltd.,1412170200,America/New_York,EDT,-14400000,0.234,3.0,hold,24264000,0.313,-15413000,0,4.577,4.631,481000,0.006,-0.2912,-0.59521,554000,-10838875,-17592000,0.96466005,0.0,-33.88565,USD,
2,8 HaSatat Street,Hevel Modi'in,7178106,Israel,972 8 993 5000,972 8 993 5001,https://www.vblrx.com,Biotechnology,Healthcare,"Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.",7,"{'maxAge': 1, 'name': 'Dr. Eyal  Breitbart Ph.D.', 'age': 55, 'title': 'Sr. VP of Research & Operations', 'yearBorn': 1967, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.2449,0.25,0.2303,0.25,0.2449,0.25,0.2303,0.25,0.0,0.817081,-0.39,192431,192431,1055709,538330,538330,0.23,0.24,1100,1000,18167876,0.101,0.32,37.771053,0.25498,0.194235,0.0,0.0,USD,-6096130,0.0,57676774,77640496,296716,517162,1690761600,1693440000,0.0038,0.13482,0.14050001,0.4,0.0039,0.273,0.85714287,1672444800,1703980800,1688083200,-15955000,-0.2,-0.6,-12.674,0.396,NCM,EQUITY,VBLT,VBLT,Vascular Biogenics Ltd.,Vascular Biogenics Ltd.,1412170200,America/New_York,EDT,-14400000,0.234,3.0,hold,24264000,0.313,-15413000,0,4.577,4.631,481000,0.006,-0.2912,-0.59521,554000,-10838875,-17592000,0.96466005,0.0,-33.88565,USD,
3,8 HaSatat Street,Hevel Modi'in,7178106,Israel,972 8 993 5000,972 8 993 5001,https://www.vblrx.com,Biotechnology,Healthcare,"Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.",7,"{'maxAge': 1, 'name': 'Advocate Ayelet  Horn', 'age': 51, 'title': 'Gen. Counsel', 'yearBorn': 1971, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.2449,0.25,0.2303,0.25,0.2449,0.25,0.2303,0.25,0.0,0.817081,-0.39,192431,192431,1055709,538330,538330,0.23,0.24,1100,1000,18167876,0.101,0.32,37.771053,0.25498,0.194235,0.0,0.0,USD,-6096130,0.0,57676774,77640496,296716,517162,1690761600,1693440000,0.0038,0.13482,0.14050001,0.4,0.0039,0.273,0.85714287,1672444800,1703980800,1688083200,-15955000,-0.2,-0.6,-12.674,0.396,NCM,EQUITY,VBLT,VBLT,Vascular Biogenics Ltd.,Vascular Biogenics Ltd.,1412170200,America/New_York,EDT,-14400000,0.234,3.0,hold,24264000,0.313,-15413000,0,4.577,4.631,481000,0.006,-0.2912,-0.59521,554000,-10838875,-17592000,0.96466005,0.0,-33.88565,USD,
4,8 HaSatat Street,Hevel Modi'in,7178106,Israel,972 8 993 5000,972 8 993 5001,https://www.vblrx.com,Biotechnology,Healthcare,"Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.",7,"{'maxAge': 1, 'name': 'Dr. Erez  Feige M.B.A., Ph.D.', 'age': 48, 'title': 'Sr. VP of Bus. Operations', 'yearBorn': 1974, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.2449,0.25,0.2303,0.25,0.2449,0.25,0.2303,0.25,0.0,0.817081,-0.39,192431,192431,1055709,538330,538330,0.23,0.24,1100,1000,18167876,0.101,0.32,37.771053,0.25498,0.194235,0.0,0.0,USD,-6096130,0.0,57676774,77640496,296716,517162,1690761600,1693440000,0.0038,0.13482,0.14050001,0.4,0.0039,0.273,0.85714287,1672444800,1703980800,1688083200,-15955000,-0.2,-0.6,-12.674,0.396,NCM,EQUITY,VBLT,VBLT,Vascular Biogenics Ltd.,Vascular Biogenics Ltd.,1412170200,America/New_York,EDT,-14400000,0.234,3.0,hold,24264000,0.313,-15413000,0,4.577,4.631,481000,0.006,-0.2912,-0.59521,554000,-10838875,-17592000,0.96466005,0.0,-33.88565,USD,
